F-star Therapeutics, Inc. EBITDA Margin 2016-2022 | FSTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for F-star Therapeutics, Inc. (FSTX) over the last 10 years. The current EBITDA margin for F-star Therapeutics, Inc. as of September 30, 2022 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2022-09-30 |
$0.02B |
$-0.04B |
-171.43% |
2021-12-31 |
$0.02B |
$-0.03B |
-142.86% |
2021-09-30 |
$0.00B |
$-0.04B |
-1075.00% |
2021-03-31 |
$0.01B |
$-0.03B |
-207.69% |
2020-12-31 |
$0.01B |
$-0.02B |
-200.00% |
2016-06-30 |
$0.00B |
$-0.02B |
inf% |
2016-03-31 |
$0.00B |
$-0.02B |
inf% |
2015-12-31 |
$0.00B |
$-0.01B |
inf% |